You are here :
Home
Healthcare Market Research Reports
| PRODUCT TITLE | PUBLISHED | |
|---|---|---|
 |
Hemodialysis The “Global Hemodialysis Market”, mainly driven by increase in the number of ESRD patient population, was pegged at $ 49.3 billion in 2012 and expected to be $ 78.2 billion by 2020, growing at a CAGR of 5.9%. Hemodialysis has 3 main segments such as Hemodialysis machines, Hemodialysis consumables and Hemodialysis services. The key players are Honeywell (U.S.), Carematix (U.S.), Philips (The Netherlands), Bosch (U.S.), Telcomed (Ireland), Intel (U.S.), Aerotel (Israel), and Tunstall (U.K.). |
Upcoming |
|
|
Thermal Ablation The Global Thermal Ablation Market, mainly driven by increasing aging population with higher risk of chronic diseases and increasing procedures through minimal invasive surgery was pegged at $9386 million in 2013 and expected to be $15480 million by 2018. The main companies operating in thermal ablation market and extensively covered in this report are Varian Medical systems, Elekta, Biosense Webster, St. Jude Medical Boston Scientfic, Accuray, Medtronic, CR Bard, Others. |
Upcoming |
|
|
Non-thermal Ablation Non-thermal Ablation and Thermal Ablation adds up to total Ablation... |
Upcoming |
|
|
Electrical Ablators The global electrical ablator market, mainly driven by the increasing aging population with higher risk of chronic disease and increasing procedures through minimal invasive surgery, was valued at $785 million in 2013 and is expected to reach $1006 million by 2018. The main companies operating in this market and extensively covered in this report are ConMed Corporation (U.S), Medtronic (U.S), Boston Scientific Corporation (U.S), AngioDynamics (U.S), and Covidien plc (Ireland). |
Upcoming |
|
|
Controlled Release Controlled Release and Orodispersible Tablets (ODT) And Taste Masking adds up to total |
Upcoming |
|
|
Orodispersible Tablets (ODT) And Taste Masking Orodispersible Tablets (ODT) And Taste Masking and Controlled Release adds up to total |
Upcoming |
|
|
Eye Drops Eye Drops and Ointments And Gels adds up to total Ocular... |
Upcoming |
|
|
Ointments And Gels Ointments And Gels and Eye Drops adds up to total Ocular Drug... |
Upcoming |
|
|
Nasal Drops Submarkets of this market are Drug Delivery Technology. Key Questions Answered What are market estimates and forecasts; which of Nasal Drops markets are doing well and which are not? What makes... |
Upcoming |
|
|
Semi-Solid Formulations Semi-Solid Formulations and Liquid Formulations and Solid... |
Upcoming |
|
|
Liquid Formulations Liquid Formulations and Semi-Solid Formulations and |
Upcoming |
|
|
Solid Formulations Solid Formulations and Semi-Solid Formulations and |
Upcoming |
|
|
Oral (Buccal And Sublingual) Submarkets of this market are Drug Delivery Technology. Key Questions Answered What are market estimates and forecasts; which of Oral (Buccal And Sublingual) markets are doing well and which are not? ... |
Upcoming |
|
|
Global Passive Transdermal Drug Delivery Market The Global Passive Transdermal Drug Delivery Market is mainly driven by patent cliffs and increased incidence of chronic diseases, increasing competition and improving patient compliance, and reformulation and repositioning of drugs, huge investment made by big pharmaceutical companies.The Market was Valued at $12.27 billion in 2013 and expected to be $20.59 billion by 2018, growing at a CAGR of 10.9 %. The Transdermal Drug Delivery Market analyzes the market by segments such as Active Transdermal Drug Delivery, and Passive Transdermal Drug Delivery. The prominent players in this Market are Novartis, Johnson & Johnson, 3M Company, Noven. |
Upcoming |
|
|
Active Active and Microfluidics, Smart Pill Technology (SPT) and Passive adds up to... |
Upcoming |
|
|
Optical Coherence Tomography Optical Coherence Tomography and Photo-Acoustic, Hyperspectral... |
Upcoming |
|
|
Photo-Acoustic Photo-Acoustic and Optical Coherence Tomography, |
Upcoming |
|
|
Near-Infrared Spectroscopy Near-Infrared Spectroscopy and Optical Coherence Tomography, |
Upcoming |
|
|
Recombinant Non-Glycosylated Proteins Recombinant Non-Glycosylated Proteins and Recombinant Glycosylated Proteins and |
Upcoming |
|
|
Recombinant Glycosylated Proteins Recombinant Glycosylated Proteins and Recombinant Non-Glycosylated Proteins and |
Upcoming |
Healthcare
